Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 58.0% to $0.1398 on volume of 323,150,710 shares Fisker Inc. Class A (FSR) fell 6.7% to $0.45 on volume of 175,737,100 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.2% to $3.115 on vol...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 33.7% to $0.4825 on volume of 369,944,141 shares Jaguar Health Inc. (JAGX) rose 50.0% to $0.0885 on volume of 303,339,477 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.6% to $3.32 on ...
CARSON CITY, Nev., March 04, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-dege...
2024-03-02 06:18:00 ET 3 Top Habits for Penny Stocks Traders to Follow in 2024 Trading penny stocks presents unique opportunities for investors looking for significant returns on investment. Despite the volatility associated with these low-priced shares, successful traders adhere to spe...
CARSON CITY, Nev., March 01, 2024 (GLOBE NEWSWIRE) -- Carson City, Nevada – March 1, 2024 – BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disea...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 44.2% to $0.0851 on volume of 271,253,038 shares Fisker Inc. Class A (FSR) fell 27.2% to $0.53 on volume of 253,915,529 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.5% to $3.325 on v...
SAN FRANCISCO, CA / ACCESSWIRE / March 1, 2024 / Hagens Berman urges BioVie Inc. (NASDAQ:BIVI) investors who suffered substantial losses to submit your losses now . Class Period: Aug. 5, 2021 - Nov. 29, 2023 Lead Plaintiff Deadline: Mar. 19, 2024 Visit: www.hbsslaw.com/investor-frau...
BioVie Inc. (NASDAQ: BIVI) is one today's most active stocks by volume. So far today, approximately 76.7M shares of BioVie Inc. have been exchanged, as compared to an average 30-day volume of 124.01k shares. BioVie Inc., a clinical stage biotechnology company, engages in the discovery, develop...
Data from Phase 2a trial in Parkinson’s Disease suggest patients treated with NE3107 experienced significant improvements in non-motor symptoms and motor control while placebo-treated patients worsened Data from Phase 3 trial in mild to moderate Alzheimer’s Disease sug...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In BioVie To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $25,000 investing in BioVie stock or options between August 5, 2021 and November 29, 2023 and...
News, Short Squeeze, Breakout and More Instantly...
BioVie Inc. Company Name:
BIVI Stock Symbol:
OTCMKTS Market:
Increasing evidence supports a role for viral persistence, chronic inflammation and immune and metabolic dysregulation in driving long COVID Bezisterim, an anti-inflammatory and insulin-sensitizer that permeates the blood brain barrier, could represent a novel oral treatment targeting a...
“Bezisterim” has been approved as the non-proprietary name for NE3107 Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation CARSON CITY, Nev., April 25, 2024 (GLOBE NEWSWIRE) -- BioV...
CARSON CITY, Nev., April 18, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, to...